HONG KONG – The CFDA's new rules covering food, drugs and medical devices give the accused the chance to petition for a hearing and outline the investigative path authorities must follow, including the use of evidence from outside of the country, before levying penalties that range from fines to shutting operations.
HONG KONG – The CFDA's new rules covering food, drugs and medical devices give the accused the chance to petition for a hearing and outline the investigative path authorities must follow, including the use of evidence from outside of the country, before levying penalties that range from fines to shutting operations.
HONG KONG – Imaging agents maker Imaginab Inc. has launched a wholly owned subsidiary – Imaginab Japan KK – in Tokyo, as part of a plan to grab a bigger share of the world's second largest pharmaceutical market.
HONG KONG – Growing domestic and international sales of vaccines buoyed strong growth for one of China's top biotechs, as reflected in its first quarter results for 2014. Beijing-based Sinovac Biotech Ltd. (NASDAQ:SVA) reported $13.5 million in sales, a jump of 34.8 percent from $10.1 million during the same period in 2013. Sinovac's shares lost 21 cents Thursday, to close at $6.06.
HONG KONG – Imaging agents maker Imaginab Inc. has launched a wholly owned subsidiary – Imaginab Japan KK – in Tokyo, as part of a plan to grab a bigger share of the world's second largest pharmaceutical market.
HONG KONG – Growing domestic and international sales of vaccines buoyed strong growth for one of China's top biotechs, as reflected in its first quarter results for 2014. Beijing-based Sinovac Biotech Ltd. (NASDAQ:SVA) reported $13.5 million in sales, a jump of 34.8 percent from $10.1 million during the same period in 2013. Sinovac's shares lost 21 cents Thursday, to close at $6.06.
HONG KONG – Aware of the business potential of the biopharmaceutical market, including the growing prospects for biosimilars, Samsung Biologics Co. Ltd. is investing $2 billion into its biopharmaceutical arms.
HONG KONG – Powered by sales of biologics and other pharmaceutical products, Wuxi Pharmatech Inc. posted strong first quarter results hurt only by a depreciation in the Chinese RMB.
HONG KONG – Merck & Co. Inc. has signed a deal to sell nine of its ophthalmic products to Japan-based Santen Pharmaceutical Co. Ltd. The decision to spin off the products to its long-time partner is Merck's latest move out of the ophthalmic market.